- List
- By Topic
- On Map
- Search Details

DCDS-4501A | Recruiting, Not yet recruiting, Available, Active, not recruiting, Enrolling by invitation Studies
Need help? See RSS Feeds
Choose a feed type:

DCDS-4501A | Recruiting, Not yet recruiting, Available, Active, not recruiting, Enrolling by invitation Studies (3 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01691898 | Active, not recruiting Has Results |
A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
230 | All | 18 Years and older (Adult, Older Adult) | NCT01691898 | GO27834 2011-004377-84 |
ROMULUS | September 27, 2012 | March 8, 2017 | February 12, 2019 | September 25, 2012 | January 24, 2019 | April 19, 2018 |
|
|
2 | NCT02257567 | Recruiting | A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma |
|
|
Interventional |
Phase 1 Phase 2 |
|
Industry |
|
|
314 | All | 18 Years and older (Adult, Older Adult) | NCT02257567 | GO29365 2014-001361-28 |
October 15, 2014 | January 2, 2020 | July 12, 2021 | October 6, 2014 | February 4, 2019 |
|
|||
3 | NCT03274492 | Recruiting | A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
875 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03274492 | GO39942 2017-002023-21 |
POLARIX | November 16, 2017 | December 17, 2019 | April 15, 2023 | September 7, 2017 | January 24, 2019 |
|
† Study has passed its completion date and status has not been verified in more than two years.